Preclinical studies demonstrate that targeting ENO1 using antibodies, small molecule inhibitors, DNA vaccines, or gene knockdown can suppress tumor growth, invasion, metastasis, and chemoresistance and may enhance the efficacy of chemotherapy [78,79,84,86,87]. This evidence concerns the gene ENO1 and neoplasm.